General
Preferred name
Estetrol
Synonyms
Donesta ()
ESTETROL ANHYDROUS ()
15.alpha.-hydroxyestriol ()
Estetrol (anhydrous) ()
E-4 ()
E4 ()
Estetrol (e4) ()
Estetrol component of nextstellis ()
E4 hydrous ()
Estetrol monohydrate ()
Estetrol (hydrate) ()
P&D ID
PD016517
CAS
15183-37-6
Tags
available
drug
Approved by
EMA
FDA
First approval
2021
Drug indication
prostate adenocarcinoma
Autoimmune diabetes
Contraception
Drug Status
approved
investigational
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Estetrol is a natural estrogen that is produced exclusively during pregnancy by the fetal liver. It is produced synthetically (from a plant source) for medicinal use. Estetrol has tissue selective actions , with estrogenic activity in the uterus, vagina and endometrium and estrogen antagonist activity in breast tissue. (GtoPdb)
DESCRIPTION Estetrol, an orally active estrogen synthesized exclusively during pregnancy by the human fetal liver, is a selective nuclear estrogen receptor modulator. Estetrol binds ER¦Á as well as ER¦Â (with a fourfold lower affinity). Estetrol increases eNOS expression/activity and NO synthesis in endothelial cells. Estetrol exerts estrogenic actions on the endometrium or the central nervous system but presents antagonistic effects on the breast. Estetrol can be used in contraception and menopausal hormone research[1][2][3][4].
PRICE 98
DESCRIPTION Estetrol is an estrogen used in combination with drospirenone for oral contraception. (Enamine Bioactive Compounds)
DESCRIPTION Estetrol is a human steroid hormone produced by fetal liver from estradiol and estriol during pregnancy. (BOC Sciences Bioactive Compounds)
DESCRIPTION Estetrol(Donesta) is an orally available, selective modulator of the estrogen receptor, a naturally occurring estrogen synthesized by the human fetal liver during pregnancy.Estetrol has effects on the endometrium or central nervous system, but is antagonistic to the breast.Estetrol may help to reduce thrombosis at low concentrations. Estetrol may be used to relieve menopausal symptoms. (TargetMol Bioactive Compound Library)
Compound Sets
16
Axon Medchem Screening Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Approved Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
Enamine Bioactive Compounds
Guide to Pharmacology
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
TargetMol Bioactive Compound Library
External IDs
50
Properties
(calculated by RDKit )
Molecular Weight
304.17
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
4
Rotatable Bonds
0
Ring Count
4
Aromatic Ring Count
1
cLogP
1.55
TPSA
80.92
Fraction CSP3
0.67
Chiral centers
7.0
Largest ring
6.0
QED
0.59
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
estrogen receptor
Endogenous Metabolite
ESR1
ER-a agonist
Estrogen Receptor/ERR
NO Synthase
MOA
Selective Estrogen Receptor Modulator (SERM)
Pathway
Immunology/Inflammation
Metabolic Enzyme/Protease
Vitamin D Related/Nuclear Receptor
Endocrinology/Hormones
Metabolism
Source data